Han Liu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Han Liu has a total of 39 co-authors. Here are the top co-authors by number of shared publications:
- Feng Wei
The First Hospital of Jilin University
17 shared publications - Fang Liu
Digestive cancer/ Pancreatic disease diagnosis and treatment center, The Affiliated Hospital of Qingdao University, Qingdao, China
16 shared publications - He Ren
Shandong Provincial Key Laboratory of Clinical Research for Pancreatic Diseases, Tumor Immunology and Cytotherapy, Medical Research Center, The Affiliated Hospital of Qingdao University, Qingdao, China
16 shared publications - Huaxin Li
Gastrointestinal Cancer Institute/Pancreatic Disease Institute, the Affiliated Hospital of Qingdao University, Shandong, China
16 shared publications - Lianjing Cao
Gastrointestinal Cancer Institute/Pancreatic Disease Institute, the Affiliated Hospital of Qingdao University, Shandong, China
16 shared publications - Tiansuo Zhao
Department of Pancreatic Cancer, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin Key Laboratory of Digestive Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, China
16 shared publications
Latest Publications
- Open Access
- 1 June 2026
- Published by KEAI Publishing in Genes & Diseases
Cancer-associated fibroblast programs across cancers: Functional axes and double-edged roles in pancreatic ductal adenocarcinoma
- 1 June 2026
- Published by KEAI Publishing in Genes & Diseases
Open AccessCancer-associated fibroblast programs across cancers: Functional axes and double-edged roles in pancreatic ductal adenocarcinoma
- Open Access
- 1 August 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S6 from Risk Stratification and Prognosis Determination Based on Protein Lysine Crotonylation in Patients with Resected Pancreatic Cancer: A Multicenter Study
Supplementary Figure S6. ROC curve analysis of the full nomogram comparing LN metastasis for predicting DFS and OS, as well as LN metastasis + TNM stage for predicting OS. ROC curve analysis of the nomogram comparing lymph node (LN) metastasis for predicting half-year, 1-year, and 2-year disease-free survival (DFS) and overall survival (OS), as well as comparing LN metastasis + TNM stage for predicting half-year, 1-year, and 2-year OS in the Qingdao (A-C), Tianjin (D-F), and Jilin cohorts (G-I).
- 1 August 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S6 from Risk Stratification and Prognosis Determination Based on Protein Lysine Crotonylation in Patients with Resected Pancreatic Cancer: A Multicenter Study
Supplementary Figure S6. ROC curve analysis of the full nomogram comparing LN metastasis for predicting DFS and OS, as well as LN metastasis + TNM stage for predicting OS. ROC curve analysis of the nomogram comparing lymph node (LN) metastasis for predicting half-year, 1-year, and 2-year disease-free survival (DFS) and overall survival (OS), as well as comparing LN metastasis + TNM stage for predicting half-year, 1-year, and 2-year OS in the Qingdao (A-C), Tianjin (D-F), and Jilin cohorts (G-I).
- Open Access
- 1 August 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Table S2 from Risk Stratification and Prognosis Determination Based on Protein Lysine Crotonylation in Patients with Resected Pancreatic Cancer: A Multicenter Study
Supplementary Table S2. Clinicopathological Characteristics of Tianjin-cohort.
- 1 August 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S2 from Risk Stratification and Prognosis Determination Based on Protein Lysine Crotonylation in Patients with Resected Pancreatic Cancer: A Multicenter Study
Supplementary Table S2. Clinicopathological Characteristics of Tianjin-cohort.
- Open Access
- 1 August 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Table S7 from Risk Stratification and Prognosis Determination Based on Protein Lysine Crotonylation in Patients with Resected Pancreatic Cancer: A Multicenter Study
Supplementary Table S7. Univariate and multivariate analyses of DFS and OS in Tianjin cohort.
- 1 August 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S7 from Risk Stratification and Prognosis Determination Based on Protein Lysine Crotonylation in Patients with Resected Pancreatic Cancer: A Multicenter Study
Supplementary Table S7. Univariate and multivariate analyses of DFS and OS in Tianjin cohort.
- Open Access
- 1 August 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Table S8 from Risk Stratification and Prognosis Determination Based on Protein Lysine Crotonylation in Patients with Resected Pancreatic Cancer: A Multicenter Study
Supplementary Table S8. Univariate and multivariate analyses of DFS and OS in Jilin cohort.
- 1 August 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S8 from Risk Stratification and Prognosis Determination Based on Protein Lysine Crotonylation in Patients with Resected Pancreatic Cancer: A Multicenter Study
Supplementary Table S8. Univariate and multivariate analyses of DFS and OS in Jilin cohort.
- Open Access
- 1 August 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S4 from Risk Stratification and Prognosis Determination Based on Protein Lysine Crotonylation in Patients with Resected Pancreatic Cancer: A Multicenter Study
Supplementary Figure S4. Decision curve analysis in the training and validation cohorts. The nomograms and 8th edition AJCC-TNM staging system for predicting half-a-year, 1-year and 2-year DFS and OS of Qingdao (A, B), Tianjin (C, D), and Jilin (E, F) cohorts.
- 1 August 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S4 from Risk Stratification and Prognosis Determination Based on Protein Lysine Crotonylation in Patients with Resected Pancreatic Cancer: A Multicenter Study
Supplementary Figure S4. Decision curve analysis in the training and validation cohorts. The nomograms and 8th edition AJCC-TNM staging system for predicting half-a-year, 1-year and 2-year DFS and OS of Qingdao (A, B), Tianjin (C, D), and Jilin (E, F) cohorts.
- Open Access
- 1 August 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Table S3 from Risk Stratification and Prognosis Determination Based on Protein Lysine Crotonylation in Patients with Resected Pancreatic Cancer: A Multicenter Study
Supplementary Table S3. Clinicopathological Characteristics of Jilin-cohort.
- 1 August 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S3 from Risk Stratification and Prognosis Determination Based on Protein Lysine Crotonylation in Patients with Resected Pancreatic Cancer: A Multicenter Study
Supplementary Table S3. Clinicopathological Characteristics of Jilin-cohort.
- Open Access
- 1 August 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Table S6 from Risk Stratification and Prognosis Determination Based on Protein Lysine Crotonylation in Patients with Resected Pancreatic Cancer: A Multicenter Study
Supplementary Table S6. Association of pan-Kcr expression with clinicopathological features in Tianjin-cohort.
- 1 August 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S6 from Risk Stratification and Prognosis Determination Based on Protein Lysine Crotonylation in Patients with Resected Pancreatic Cancer: A Multicenter Study
Supplementary Table S6. Association of pan-Kcr expression with clinicopathological features in Tianjin-cohort.
- Open Access
- 1 August 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S2 from Risk Stratification and Prognosis Determination Based on Protein Lysine Crotonylation in Patients with Resected Pancreatic Cancer: A Multicenter Study
Supplementary Figure S2. Prognostic significance of pan-Kcr expression in PDAC patients of all three cohorts. Kaplan-Meier estimates of DFS (A) and OS (B) for patients with high and low pan-Kcr expression based on all three cohorts.
- 1 August 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S2 from Risk Stratification and Prognosis Determination Based on Protein Lysine Crotonylation in Patients with Resected Pancreatic Cancer: A Multicenter Study
Supplementary Figure S2. Prognostic significance of pan-Kcr expression in PDAC patients of all three cohorts. Kaplan-Meier estimates of DFS (A) and OS (B) for patients with high and low pan-Kcr expression based on all three cohorts.
- Open Access
- 1 August 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Table S4 from Risk Stratification and Prognosis Determination Based on Protein Lysine Crotonylation in Patients with Resected Pancreatic Cancer: A Multicenter Study
Supplementary Table S4. Association of pan-Kcr expression with clinicopathological features in Qingdao-cohort.
- 1 August 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S4 from Risk Stratification and Prognosis Determination Based on Protein Lysine Crotonylation in Patients with Resected Pancreatic Cancer: A Multicenter Study
Supplementary Table S4. Association of pan-Kcr expression with clinicopathological features in Qingdao-cohort.